Travere Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Travere Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • Travere Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 29, 2024 was 76.5M shares, a 1.97% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 76.5M +1.48M +1.97% Jul 29, 2024 10-Q 2024-08-01
Q1 2024 76.1M +1.52M +2.04% May 2, 2024 10-Q 2024-05-06
Q3 2023 75.1M +11M +17.1% Nov 3, 2023 10-Q 2023-11-07
Q2 2023 75M +11.1M +17.3% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 74.6M +11.1M +17.5% May 2, 2023 10-Q 2023-05-04
Q3 2022 64.2M +2.95M +4.81% Oct 25, 2022 10-Q 2022-10-27
Q2 2022 64M +3.24M +5.34% Aug 2, 2022 10-Q 2022-08-04
Q1 2022 63.5M +3.06M +5.06% May 3, 2022 10-Q 2022-05-05
Q3 2021 61.2M +10.2M +19.9% Oct 26, 2021 10-Q 2021-10-29
Q2 2021 60.7M +9.81M +19.3% Jul 27, 2021 10-Q 2021-07-29
Q1 2021 60.5M +17.3M +40.1% May 4, 2021 10-Q 2021-05-06
Q3 2020 51.1M +8.09M +18.8% Nov 3, 2020 10-Q 2020-11-05
Q2 2020 50.9M +7.95M +18.5% Jul 29, 2020 10-Q 2020-07-31
Q1 2020 43.2M +1.74M +4.21% May 7, 2020 10-Q 2020-05-11
Q3 2019 43M +1.71M +4.15% Oct 29, 2019 10-Q 2019-10-30
Q2 2019 43M +2.53M +6.25% Aug 5, 2019 10-Q 2019-08-06
Q1 2019 41.4M +1.47M +3.68% Feb 25, 2019 10-K 2019-02-26
Q3 2018 41.2M +1.94M +4.94% Nov 1, 2018 10-Q 2018-11-01
Q2 2018 40.4M +2.04M +5.32% Aug 1, 2018 10-Q 2018-08-03
Q1 2018 39.9M +1.85M +4.86% Apr 30, 2018 10-Q/A 2018-07-06
Q3 2017 39.3M +1.57M +4.17% Nov 6, 2017 10-Q 2017-11-07
Q2 2017 38.4M +1.65M +4.5% Aug 8, 2017 10-Q 2017-08-09
Q1 2017 38.1M +1.42M +3.86% Feb 28, 2017 10-K 2017-03-01
Q3 2016 37.7M +1.58M +4.38% Nov 3, 2016 10-Q 2016-11-04
Q2 2016 36.7M +1.66M +4.73% Aug 4, 2016 10-Q 2016-08-05
Q1 2016 36.7M +10.2M +38.5% May 4, 2016 10-Q 2016-05-05
Q3 2015 36.1M +9.45M +35.4% Nov 2, 2015 10-Q 2015-11-06
Q2 2015 35.1M +8.39M +31.5% Jun 30, 2015 10-K/A 2015-07-09
Q1 2015 26.5M +2.22M +9.17% Mar 3, 2015 10-K 2015-03-11
Q3 2014 26.7M +8.55M +47.1% Nov 12, 2014 10-Q 2014-11-13
Q2 2014 26.7M +14.6M +121% Aug 12, 2014 10-Q 2014-08-14
Q1 2014 24.3M +12.2M +101% Mar 19, 2014 10-K 2014-03-28
Q3 2013 18.2M +18M +16912% Sep 13, 2013 10-Q 2013-09-16
Q2 2013 12.1M +12M +11236% Jul 18, 2013 10-Q 2013-07-24
Q1 2013 12.1M +12M +11211% Feb 28, 2013 10-Q 2013-03-06
Q3 2012 107K -852K -88.9% Aug 31, 2012 10-Q 2012-10-10
Q2 2012 107K May 31, 2012 10-Q 2012-08-08
Q1 2012 107K Feb 29, 2012 10-K 2012-05-24
Q4 2011 959K Nov 30, 2011 10-Q 2012-01-11
Q3 2011 959K Aug 31, 2011 10-Q/A 2012-06-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.